Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products

Eli Lilly (NYSE: LLY) took another big swipe at America's rebate-hungry reimbursement system by launching a generic competitor for two more of its popular insulin lispro containing products.